— Know what they know.
Not Investment Advice

CPIX NASDAQ

Cumberland Pharmaceuticals Inc.
1W: -2.9% 1M: +13.3% 3M: +20.0% YTD: +85.7% 1Y: +136.9% 3Y: +255.3% 5Y: +171.7%
$7.39
-0.12 (-1.60%)
 
Weekly Expected Move ±8.0%
$6 $7 $7 $8 $9
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 65 · $110.7M mcap · 9M float · 0.993% daily turnover · Short 41% of daily vol

Supply Chain Overview

2 relationships
2
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2021-11-19
Earliest Filing
2022-01-06
Latest Filing
target: 1 partner: 1

Counterparties (Filed by CPIX)

2 relationships

Companies named in CPIX's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Kyowa Kirin, Inc. — target Sold U.S. rights to SANCUSO® to Cumberland Pharmaceuticals Inc. 2022-01-06 View
1600 West End Avenue Partners, LLC — partner Leased the new corporate headquarters building to Cumberland Pharmaceuticals Inc. 2021-11-19 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-09-11 Shareholder Vote View
2026-08-28 Regulation FD View
2026-08-04 Earnings Release; Exhibits View
2026-07-13 Other Events View
2026-07-01 Material Agreement; Termination of Agreement; Acquisition/Disposition; Officer/Director Change; Othe Agreement Acquisition View
2026-06-25 Shareholder Vote View
2026-05-05 Earnings Release; Exhibits View
2026-04-24 Shareholder Vote View
2026-04-23 Material Agreement; Regulation FD; Other Events; Exhibits Agreement View
2026-03-03 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2026-02-04 Other Events View
2025-11-24 Entry into Material Definitive Agreement; Creation of Direct Financial Obligation Agreement View
2025-11-04 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-10-21 Other Events View
2025-08-05 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-05-06 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-04-28 Submission of Matters to a Vote of Security Holders View
2025-03-19 Other Events View
2025-03-04 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-02-19 Other Events View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms